nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2A6—Progesterone—uterine cancer	0.142	0.219	CbGbCtD
Eletriptan—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0736	0.114	CbGbCtD
Eletriptan—CYP2C19—Progesterone—uterine cancer	0.0587	0.0905	CbGbCtD
Eletriptan—PTGS1—Etoposide—uterine cancer	0.0542	0.0836	CbGbCtD
Eletriptan—CYP2C9—Progesterone—uterine cancer	0.0488	0.0752	CbGbCtD
Eletriptan—ABCB1—Progesterone—uterine cancer	0.0473	0.073	CbGbCtD
Eletriptan—CYP2D6—Progesterone—uterine cancer	0.0446	0.0688	CbGbCtD
Eletriptan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0428	0.066	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—uterine cancer	0.0375	0.0579	CbGbCtD
Eletriptan—CYP3A4—Progesterone—uterine cancer	0.0284	0.0437	CbGbCtD
Eletriptan—ABCB1—Etoposide—uterine cancer	0.0212	0.0327	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—uterine cancer	0.0144	0.0223	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—uterine cancer	0.0136	0.021	CbGbCtD
Eletriptan—CYP3A4—Etoposide—uterine cancer	0.0127	0.0196	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—uterine cancer	0.00865	0.0134	CbGbCtD
Eletriptan—HTR1E—myometrium—uterine cancer	0.00395	0.0702	CbGeAlD
Eletriptan—HTR1B—artery—uterine cancer	0.00386	0.0687	CbGeAlD
Eletriptan—HTR1D—artery—uterine cancer	0.00374	0.0665	CbGeAlD
Eletriptan—PTGS1—oviduct—uterine cancer	0.00311	0.0553	CbGeAlD
Eletriptan—HTR7—artery—uterine cancer	0.00298	0.053	CbGeAlD
Eletriptan—HTR1E—female gonad—uterine cancer	0.00209	0.0372	CbGeAlD
Eletriptan—PTGS1—artery—uterine cancer	0.00206	0.0366	CbGeAlD
Eletriptan—HTR2B—myometrium—uterine cancer	0.00168	0.0299	CbGeAlD
Eletriptan—HTR2B—uterine cervix—uterine cancer	0.00131	0.0233	CbGeAlD
Eletriptan—HTR2B—smooth muscle tissue—uterine cancer	0.00127	0.0226	CbGeAlD
Eletriptan—HTR2B—decidua—uterine cancer	0.00125	0.0222	CbGeAlD
Eletriptan—HTR2B—endometrium—uterine cancer	0.00118	0.021	CbGeAlD
Eletriptan—CYP2A6—vagina—uterine cancer	0.00115	0.0205	CbGeAlD
Eletriptan—HTR7—epithelium—uterine cancer	0.00113	0.0201	CbGeAlD
Eletriptan—HTR1A—renal system—uterine cancer	0.0011	0.0195	CbGeAlD
Eletriptan—HTR2B—uterus—uterine cancer	0.00109	0.0194	CbGeAlD
Eletriptan—HTR7—smooth muscle tissue—uterine cancer	0.00109	0.0194	CbGeAlD
Eletriptan—HTR1B—female reproductive system—uterine cancer	0.00109	0.0193	CbGeAlD
Eletriptan—HTR1D—female reproductive system—uterine cancer	0.00105	0.0187	CbGeAlD
Eletriptan—HTR7—renal system—uterine cancer	0.00105	0.0186	CbGeAlD
Eletriptan—HTR2B—female reproductive system—uterine cancer	0.00098	0.0174	CbGeAlD
Eletriptan—HTR2B—vagina—uterine cancer	0.000886	0.0158	CbGeAlD
Eletriptan—HTR7—female reproductive system—uterine cancer	0.000839	0.0149	CbGeAlD
Eletriptan—PTGS1—epithelium—uterine cancer	0.000781	0.0139	CbGeAlD
Eletriptan—PTGS1—uterine cervix—uterine cancer	0.000774	0.0138	CbGeAlD
Eletriptan—PTGS1—smooth muscle tissue—uterine cancer	0.000752	0.0134	CbGeAlD
Eletriptan—CYP2C19—vagina—uterine cancer	0.000741	0.0132	CbGeAlD
Eletriptan—PTGS1—renal system—uterine cancer	0.000724	0.0129	CbGeAlD
Eletriptan—PTGS1—endometrium—uterine cancer	0.0007	0.0124	CbGeAlD
Eletriptan—PTGS1—mammalian vulva—uterine cancer	0.000677	0.012	CbGeAlD
Eletriptan—PTGS1—uterus—uterine cancer	0.000645	0.0115	CbGeAlD
Eletriptan—CYP2C9—female reproductive system—uterine cancer	0.000635	0.0113	CbGeAlD
Eletriptan—CYP3A4—renal system—uterine cancer	0.000605	0.0108	CbGeAlD
Eletriptan—CYP2D6—renal system—uterine cancer	0.000595	0.0106	CbGeAlD
Eletriptan—ABCB1—myometrium—uterine cancer	0.000588	0.0105	CbGeAlD
Eletriptan—PTGS1—female reproductive system—uterine cancer	0.00058	0.0103	CbGeAlD
Eletriptan—HTR2B—lymph node—uterine cancer	0.000573	0.0102	CbGeAlD
Eletriptan—PTGS1—female gonad—uterine cancer	0.000528	0.00938	CbGeAlD
Eletriptan—PTGS1—vagina—uterine cancer	0.000525	0.00933	CbGeAlD
Eletriptan—CYP3A4—female reproductive system—uterine cancer	0.000485	0.00861	CbGeAlD
Eletriptan—CYP2D6—female reproductive system—uterine cancer	0.000477	0.00848	CbGeAlD
Eletriptan—ABCB1—epithelium—uterine cancer	0.000462	0.00821	CbGeAlD
Eletriptan—ABCB1—uterine cervix—uterine cancer	0.000458	0.00814	CbGeAlD
Eletriptan—ABCB1—decidua—uterine cancer	0.000436	0.00775	CbGeAlD
Eletriptan—CYP2D6—female gonad—uterine cancer	0.000434	0.00771	CbGeAlD
Eletriptan—ABCB1—renal system—uterine cancer	0.000428	0.00761	CbGeAlD
Eletriptan—ABCB1—endometrium—uterine cancer	0.000414	0.00736	CbGeAlD
Eletriptan—ABCB1—mammalian vulva—uterine cancer	0.0004	0.00712	CbGeAlD
Eletriptan—ABCB1—uterus—uterine cancer	0.000382	0.00678	CbGeAlD
Eletriptan—ABCB1—female reproductive system—uterine cancer	0.000343	0.0061	CbGeAlD
Eletriptan—PTGS1—lymph node—uterine cancer	0.000339	0.00603	CbGeAlD
Eletriptan—ABCB1—female gonad—uterine cancer	0.000312	0.00555	CbGeAlD
Eletriptan—ABCB1—vagina—uterine cancer	0.00031	0.00551	CbGeAlD
Eletriptan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000255	0.000876	CcSEcCtD
Eletriptan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.000871	CcSEcCtD
Eletriptan—Malaise—Etoposide—uterine cancer	0.000252	0.000867	CcSEcCtD
Eletriptan—Face oedema—Epirubicin—uterine cancer	0.000251	0.000864	CcSEcCtD
Eletriptan—Vertigo—Etoposide—uterine cancer	0.000251	0.000864	CcSEcCtD
Eletriptan—Leukopenia—Etoposide—uterine cancer	0.00025	0.000861	CcSEcCtD
Eletriptan—Purpura—Doxorubicin—uterine cancer	0.00025	0.000859	CcSEcCtD
Eletriptan—Body temperature increased—Dactinomycin—uterine cancer	0.000249	0.000857	CcSEcCtD
Eletriptan—Abdominal pain—Dactinomycin—uterine cancer	0.000249	0.000857	CcSEcCtD
Eletriptan—Mood swings—Epirubicin—uterine cancer	0.000247	0.000848	CcSEcCtD
Eletriptan—Loss of consciousness—Etoposide—uterine cancer	0.000246	0.000845	CcSEcCtD
Eletriptan—Ataxia—Epirubicin—uterine cancer	0.000245	0.000842	CcSEcCtD
Eletriptan—Cough—Etoposide—uterine cancer	0.000244	0.000839	CcSEcCtD
Eletriptan—Convulsion—Etoposide—uterine cancer	0.000242	0.000833	CcSEcCtD
Eletriptan—Hypertension—Etoposide—uterine cancer	0.000242	0.00083	CcSEcCtD
Eletriptan—Diplopia—Doxorubicin—uterine cancer	0.000241	0.000828	CcSEcCtD
Eletriptan—Osteoarthritis—Doxorubicin—uterine cancer	0.000241	0.000828	CcSEcCtD
Eletriptan—Liver function test abnormal—Epirubicin—uterine cancer	0.00024	0.000826	CcSEcCtD
Eletriptan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.000826	CcSEcCtD
Eletriptan—Dry skin—Epirubicin—uterine cancer	0.000239	0.000821	CcSEcCtD
Eletriptan—Abdominal pain upper—Epirubicin—uterine cancer	0.000238	0.000818	CcSEcCtD
Eletriptan—Migraine—Doxorubicin—uterine cancer	0.000237	0.000815	CcSEcCtD
Eletriptan—Affect lability—Doxorubicin—uterine cancer	0.000237	0.000815	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000237	0.000813	CcSEcCtD
Eletriptan—Discomfort—Etoposide—uterine cancer	0.000235	0.000809	CcSEcCtD
Eletriptan—Face oedema—Doxorubicin—uterine cancer	0.000233	0.0008	CcSEcCtD
Eletriptan—Hypersensitivity—Dactinomycin—uterine cancer	0.000232	0.000799	CcSEcCtD
Eletriptan—Gastritis—Epirubicin—uterine cancer	0.000231	0.000792	CcSEcCtD
Eletriptan—Confusional state—Etoposide—uterine cancer	0.00023	0.000791	CcSEcCtD
Eletriptan—Muscular weakness—Epirubicin—uterine cancer	0.00023	0.00079	CcSEcCtD
Eletriptan—Mood swings—Doxorubicin—uterine cancer	0.000228	0.000785	CcSEcCtD
Eletriptan—Abdominal distension—Epirubicin—uterine cancer	0.000227	0.000779	CcSEcCtD
Eletriptan—Ataxia—Doxorubicin—uterine cancer	0.000227	0.000779	CcSEcCtD
Eletriptan—Asthenia—Dactinomycin—uterine cancer	0.000226	0.000778	CcSEcCtD
Eletriptan—Asthma—Epirubicin—uterine cancer	0.000225	0.000774	CcSEcCtD
Eletriptan—Dysphagia—Epirubicin—uterine cancer	0.000225	0.000774	CcSEcCtD
Eletriptan—Influenza—Epirubicin—uterine cancer	0.000225	0.000774	CcSEcCtD
Eletriptan—Tachycardia—Etoposide—uterine cancer	0.000223	0.000766	CcSEcCtD
Eletriptan—Liver function test abnormal—Doxorubicin—uterine cancer	0.000223	0.000765	CcSEcCtD
Eletriptan—Skin disorder—Etoposide—uterine cancer	0.000222	0.000762	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—uterine cancer	0.000221	0.000759	CcSEcCtD
Eletriptan—Hyperhidrosis—Etoposide—uterine cancer	0.000221	0.000759	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—uterine cancer	0.00022	0.000757	CcSEcCtD
Eletriptan—Angina pectoris—Epirubicin—uterine cancer	0.000219	0.000754	CcSEcCtD
Eletriptan—Anorexia—Etoposide—uterine cancer	0.000218	0.000748	CcSEcCtD
Eletriptan—Bronchitis—Epirubicin—uterine cancer	0.000217	0.000744	CcSEcCtD
Eletriptan—Diarrhoea—Dactinomycin—uterine cancer	0.000216	0.000742	CcSEcCtD
Eletriptan—Hypotension—Etoposide—uterine cancer	0.000213	0.000733	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—uterine cancer	0.000213	0.000733	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—uterine cancer	0.000213	0.000731	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—uterine cancer	0.00021	0.000721	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—uterine cancer	0.000208	0.000716	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—uterine cancer	0.000208	0.000716	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—uterine cancer	0.000208	0.000716	CcSEcCtD
Eletriptan—Pollakiuria—Epirubicin—uterine cancer	0.000208	0.000715	CcSEcCtD
Eletriptan—Paraesthesia—Etoposide—uterine cancer	0.000205	0.000705	CcSEcCtD
Eletriptan—Weight increased—Epirubicin—uterine cancer	0.000205	0.000704	CcSEcCtD
Eletriptan—Weight decreased—Epirubicin—uterine cancer	0.000204	0.0007	CcSEcCtD
Eletriptan—Dyspnoea—Etoposide—uterine cancer	0.000204	0.0007	CcSEcCtD
Eletriptan—Hyperglycaemia—Epirubicin—uterine cancer	0.000203	0.000698	CcSEcCtD
Eletriptan—Somnolence—Etoposide—uterine cancer	0.000203	0.000698	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—uterine cancer	0.000203	0.000697	CcSEcCtD
Eletriptan—Drowsiness—Epirubicin—uterine cancer	0.000201	0.00069	CcSEcCtD
Eletriptan—Vomiting—Dactinomycin—uterine cancer	0.000201	0.00069	CcSEcCtD
Eletriptan—ABCB1—lymph node—uterine cancer	0.000201	0.00357	CbGeAlD
Eletriptan—Bronchitis—Doxorubicin—uterine cancer	0.0002	0.000688	CcSEcCtD
Eletriptan—Rash—Dactinomycin—uterine cancer	0.000199	0.000684	CcSEcCtD
Eletriptan—Decreased appetite—Etoposide—uterine cancer	0.000199	0.000682	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000197	0.000678	CcSEcCtD
Eletriptan—Fatigue—Etoposide—uterine cancer	0.000197	0.000677	CcSEcCtD
Eletriptan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000197	0.000676	CcSEcCtD
Eletriptan—Stomatitis—Epirubicin—uterine cancer	0.000196	0.000672	CcSEcCtD
Eletriptan—Pain—Etoposide—uterine cancer	0.000195	0.000671	CcSEcCtD
Eletriptan—Constipation—Etoposide—uterine cancer	0.000195	0.000671	CcSEcCtD
Eletriptan—Conjunctivitis—Epirubicin—uterine cancer	0.000195	0.000671	CcSEcCtD
Eletriptan—Sweating—Epirubicin—uterine cancer	0.000192	0.000661	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—uterine cancer	0.000192	0.000661	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—uterine cancer	0.00019	0.000652	CcSEcCtD
Eletriptan—Epistaxis—Epirubicin—uterine cancer	0.000189	0.000651	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—uterine cancer	0.000188	0.000648	CcSEcCtD
Eletriptan—Sinusitis—Epirubicin—uterine cancer	0.000188	0.000647	CcSEcCtD
Eletriptan—Feeling abnormal—Etoposide—uterine cancer	0.000188	0.000647	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—uterine cancer	0.000188	0.000646	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—uterine cancer	0.000187	0.000644	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etoposide—uterine cancer	0.000187	0.000642	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—uterine cancer	0.000186	0.000638	CcSEcCtD
Eletriptan—Bradycardia—Epirubicin—uterine cancer	0.000183	0.00063	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000182	0.000626	CcSEcCtD
Eletriptan—Urticaria—Etoposide—uterine cancer	0.000181	0.000624	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—uterine cancer	0.000181	0.000622	CcSEcCtD
Eletriptan—Rhinitis—Epirubicin—uterine cancer	0.000181	0.000621	CcSEcCtD
Eletriptan—Abdominal pain—Etoposide—uterine cancer	0.000181	0.00062	CcSEcCtD
Eletriptan—Body temperature increased—Etoposide—uterine cancer	0.000181	0.00062	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—uterine cancer	0.000181	0.00062	CcSEcCtD
Eletriptan—Hypoaesthesia—Epirubicin—uterine cancer	0.000179	0.000616	CcSEcCtD
Eletriptan—Pharyngitis—Epirubicin—uterine cancer	0.000179	0.000615	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—uterine cancer	0.000178	0.000612	CcSEcCtD
Eletriptan—Urinary tract disorder—Epirubicin—uterine cancer	0.000178	0.000612	CcSEcCtD
Eletriptan—Oedema peripheral—Epirubicin—uterine cancer	0.000178	0.00061	CcSEcCtD
Eletriptan—Urethral disorder—Epirubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—uterine cancer	0.000175	0.000602	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—uterine cancer	0.000174	0.000599	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—uterine cancer	0.000174	0.000597	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—uterine cancer	0.00017	0.000583	CcSEcCtD
Eletriptan—Hypersensitivity—Etoposide—uterine cancer	0.000168	0.000578	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—uterine cancer	0.000168	0.000577	CcSEcCtD
Eletriptan—Flushing—Epirubicin—uterine cancer	0.000167	0.000575	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—uterine cancer	0.000167	0.000574	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—uterine cancer	0.000166	0.00057	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—uterine cancer	0.000165	0.000569	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—uterine cancer	0.000165	0.000566	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—uterine cancer	0.000164	0.000564	CcSEcCtD
Eletriptan—Asthenia—Etoposide—uterine cancer	0.000164	0.000563	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—uterine cancer	0.000163	0.000562	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—uterine cancer	0.000163	0.000559	CcSEcCtD
Eletriptan—Chills—Epirubicin—uterine cancer	0.000162	0.000556	CcSEcCtD
Eletriptan—Pruritus—Etoposide—uterine cancer	0.000162	0.000555	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—uterine cancer	0.000161	0.000553	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—uterine cancer	0.000161	0.000552	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—uterine cancer	0.000159	0.000547	CcSEcCtD
Eletriptan—Diarrhoea—Etoposide—uterine cancer	0.000156	0.000537	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—uterine cancer	0.000155	0.000534	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—uterine cancer	0.000155	0.000532	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—uterine cancer	0.000155	0.000531	CcSEcCtD
Eletriptan—Tension—Epirubicin—uterine cancer	0.000154	0.000529	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—uterine cancer	0.000154	0.000528	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—uterine cancer	0.000152	0.000524	CcSEcCtD
Eletriptan—Back pain—Epirubicin—uterine cancer	0.000152	0.000521	CcSEcCtD
Eletriptan—Dizziness—Etoposide—uterine cancer	0.000151	0.000519	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—uterine cancer	0.000151	0.000518	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—uterine cancer	0.000151	0.000518	CcSEcCtD
Eletriptan—Chills—Doxorubicin—uterine cancer	0.00015	0.000514	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—uterine cancer	0.000149	0.000512	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—uterine cancer	0.000147	0.000506	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—uterine cancer	0.000146	0.0005	CcSEcCtD
Eletriptan—Vomiting—Etoposide—uterine cancer	0.000145	0.000499	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—uterine cancer	0.000145	0.000498	CcSEcCtD
Eletriptan—Agitation—Epirubicin—uterine cancer	0.000144	0.000495	CcSEcCtD
Eletriptan—Rash—Etoposide—uterine cancer	0.000144	0.000495	CcSEcCtD
Eletriptan—Dermatitis—Etoposide—uterine cancer	0.000144	0.000494	CcSEcCtD
Eletriptan—Headache—Etoposide—uterine cancer	0.000143	0.000492	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—uterine cancer	0.000143	0.000492	CcSEcCtD
Eletriptan—Tension—Doxorubicin—uterine cancer	0.000142	0.000489	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—uterine cancer	0.000142	0.000488	CcSEcCtD
Eletriptan—Malaise—Epirubicin—uterine cancer	0.000141	0.000486	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—uterine cancer	0.000141	0.000484	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—uterine cancer	0.000141	0.000484	CcSEcCtD
Eletriptan—Syncope—Epirubicin—uterine cancer	0.000141	0.000483	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—uterine cancer	0.00014	0.000483	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—uterine cancer	0.00014	0.000483	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—uterine cancer	0.00014	0.00048	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—uterine cancer	0.000139	0.000476	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—uterine cancer	0.000138	0.000474	CcSEcCtD
Eletriptan—Cough—Epirubicin—uterine cancer	0.000137	0.00047	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—uterine cancer	0.000136	0.000467	CcSEcCtD
Eletriptan—Nausea—Etoposide—uterine cancer	0.000136	0.000466	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—uterine cancer	0.000135	0.000465	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—uterine cancer	0.000135	0.000463	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—uterine cancer	0.000134	0.000461	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—uterine cancer	0.000134	0.000459	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—uterine cancer	0.000134	0.000459	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—uterine cancer	0.000133	0.000458	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—uterine cancer	0.000133	0.000457	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000133	0.000456	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—uterine cancer	0.000132	0.000453	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—uterine cancer	0.000131	0.00045	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—uterine cancer	0.000131	0.000449	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—uterine cancer	0.00013	0.000448	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—uterine cancer	0.00013	0.000447	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—uterine cancer	0.00013	0.000447	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—uterine cancer	0.000129	0.000444	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—uterine cancer	0.000128	0.000441	CcSEcCtD
Eletriptan—Oedema—Epirubicin—uterine cancer	0.000128	0.00044	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—uterine cancer	0.000128	0.000438	CcSEcCtD
Eletriptan—Cough—Doxorubicin—uterine cancer	0.000127	0.000435	CcSEcCtD
Eletriptan—Shock—Epirubicin—uterine cancer	0.000126	0.000433	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—uterine cancer	0.000126	0.000432	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—uterine cancer	0.000126	0.000431	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—uterine cancer	0.000125	0.000431	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—uterine cancer	0.000125	0.000429	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—uterine cancer	0.000124	0.000427	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—uterine cancer	0.000123	0.000423	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000123	0.000422	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—uterine cancer	0.000122	0.00042	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—uterine cancer	0.000122	0.000419	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—uterine cancer	0.000121	0.000415	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—uterine cancer	0.00012	0.000411	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—uterine cancer	0.000119	0.00041	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—uterine cancer	0.000118	0.000407	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000117	0.000401	CcSEcCtD
Eletriptan—Shock—Doxorubicin—uterine cancer	0.000117	0.000401	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—uterine cancer	0.000116	0.000399	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—uterine cancer	0.000116	0.000398	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—uterine cancer	0.000116	0.000397	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—uterine cancer	0.000115	0.000395	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—uterine cancer	0.000115	0.000395	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000115	0.000394	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—uterine cancer	0.000114	0.000392	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—uterine cancer	0.000114	0.000391	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—uterine cancer	0.000113	0.000388	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—uterine cancer	0.000113	0.000387	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—uterine cancer	0.000111	0.000382	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—uterine cancer	0.000111	0.00038	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000111	0.00038	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—uterine cancer	0.00011	0.000379	CcSEcCtD
Eletriptan—Constipation—Epirubicin—uterine cancer	0.000109	0.000376	CcSEcCtD
Eletriptan—Pain—Epirubicin—uterine cancer	0.000109	0.000376	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000108	0.000371	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—uterine cancer	0.000107	0.000368	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—uterine cancer	0.000106	0.000366	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—uterine cancer	0.000106	0.000363	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—uterine cancer	0.000105	0.000363	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—uterine cancer	0.000105	0.000362	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000105	0.00036	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—uterine cancer	0.000104	0.000358	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—uterine cancer	0.000103	0.000354	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000102	0.000351	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—uterine cancer	0.000102	0.000351	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—uterine cancer	0.000102	0.00035	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Eletriptan—Pain—Doxorubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—uterine cancer	9.76e-05	0.000335	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—uterine cancer	9.69e-05	0.000333	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—uterine cancer	9.43e-05	0.000324	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—uterine cancer	9.41e-05	0.000323	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—uterine cancer	9.36e-05	0.000322	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—uterine cancer	9.36e-05	0.000322	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—uterine cancer	9.19e-05	0.000316	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—uterine cancer	9.06e-05	0.000311	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—uterine cancer	8.76e-05	0.000301	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—uterine cancer	8.73e-05	0.0003	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—uterine cancer	8.5e-05	0.000292	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—uterine cancer	8.47e-05	0.000291	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—uterine cancer	8.38e-05	0.000288	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—uterine cancer	8.14e-05	0.00028	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—uterine cancer	8.1e-05	0.000279	CcSEcCtD
Eletriptan—Rash—Epirubicin—uterine cancer	8.07e-05	0.000277	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—uterine cancer	8.06e-05	0.000277	CcSEcCtD
Eletriptan—Headache—Epirubicin—uterine cancer	8.02e-05	0.000276	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—uterine cancer	7.83e-05	0.000269	CcSEcCtD
Eletriptan—Nausea—Epirubicin—uterine cancer	7.6e-05	0.000261	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—uterine cancer	7.53e-05	0.000259	CcSEcCtD
Eletriptan—Rash—Doxorubicin—uterine cancer	7.47e-05	0.000257	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—uterine cancer	7.46e-05	0.000256	CcSEcCtD
Eletriptan—Headache—Doxorubicin—uterine cancer	7.42e-05	0.000255	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—uterine cancer	7.04e-05	0.000242	CcSEcCtD
Eletriptan—ABCB1—Metabolism—AKR1C1—uterine cancer	2.66e-06	0.000583	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POLD1—uterine cancer	2.66e-06	0.000583	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—KRAS—uterine cancer	2.64e-06	0.000579	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SMAD3—uterine cancer	2.64e-06	0.000578	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1R—uterine cancer	2.63e-06	0.000578	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL8—uterine cancer	2.62e-06	0.000575	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL8—uterine cancer	2.61e-06	0.000572	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL8—uterine cancer	2.59e-06	0.000568	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FGFR2—uterine cancer	2.58e-06	0.000567	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PIK3CA—uterine cancer	2.57e-06	0.000564	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FGFR2—uterine cancer	2.57e-06	0.000564	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.54e-06	0.000557	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL8—uterine cancer	2.53e-06	0.000556	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.53e-06	0.000555	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ERBB2—uterine cancer	2.52e-06	0.000553	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FGFR2—uterine cancer	2.51e-06	0.000552	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.51e-06	0.00055	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.48e-06	0.000545	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SMAD3—uterine cancer	2.48e-06	0.000543	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STK11—uterine cancer	2.45e-06	0.000538	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.45e-06	0.000537	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCL2—uterine cancer	2.44e-06	0.000536	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RRM2—uterine cancer	2.43e-06	0.000533	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PIK3CA—uterine cancer	2.42e-06	0.000532	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL8—uterine cancer	2.39e-06	0.000525	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL8—uterine cancer	2.38e-06	0.000523	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ERBB2—uterine cancer	2.38e-06	0.000522	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HRAS—uterine cancer	2.38e-06	0.000521	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RRM2—uterine cancer	2.37e-06	0.00052	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGFR2—uterine cancer	2.36e-06	0.000518	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—DCN—uterine cancer	2.36e-06	0.000517	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CDKN1B—uterine cancer	2.34e-06	0.000512	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKT1—uterine cancer	2.31e-06	0.000507	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—DCN—uterine cancer	2.3e-06	0.000505	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SOCS3—uterine cancer	2.3e-06	0.000504	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL8—uterine cancer	2.26e-06	0.000495	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HRAS—uterine cancer	2.24e-06	0.000492	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RRM2—uterine cancer	2.23e-06	0.00049	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.23e-06	0.00049	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—STAR—uterine cancer	2.23e-06	0.00049	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.22e-06	0.000487	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RRM2—uterine cancer	2.21e-06	0.000486	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ESR1—uterine cancer	2.21e-06	0.000485	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CTNNB1—uterine cancer	2.21e-06	0.000484	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CDKN1B—uterine cancer	2.2e-06	0.000483	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN2B—uterine cancer	2.2e-06	0.000483	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ESR1—uterine cancer	2.2e-06	0.000482	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—uterine cancer	2.18e-06	0.000478	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—DCN—uterine cancer	2.17e-06	0.000476	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP11A1—uterine cancer	2.17e-06	0.000476	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ESR1—uterine cancer	2.15e-06	0.000472	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTEN—uterine cancer	2.15e-06	0.000472	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—DCN—uterine cancer	2.15e-06	0.000472	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1R—uterine cancer	2.14e-06	0.000469	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MTHFR—uterine cancer	2.13e-06	0.000467	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL8—uterine cancer	2.13e-06	0.000467	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—uterine cancer	2.1e-06	0.00046	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.1e-06	0.00046	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—NRAS—uterine cancer	2.09e-06	0.000459	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CTNNB1—uterine cancer	2.08e-06	0.000457	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—NRAS—uterine cancer	2.08e-06	0.000456	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.07e-06	0.000453	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EP300—uterine cancer	2.05e-06	0.00045	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKR1C3—uterine cancer	2.05e-06	0.000449	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.04e-06	0.000448	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—NRAS—uterine cancer	2.03e-06	0.000446	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTEN—uterine cancer	2.03e-06	0.000445	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.02e-06	0.000444	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ESR1—uterine cancer	2.02e-06	0.000443	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MTHFR—uterine cancer	2.01e-06	0.000442	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SMAD3—uterine cancer	2.01e-06	0.000441	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—uterine cancer	1.98e-06	0.000434	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL2—uterine cancer	1.95e-06	0.000427	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—uterine cancer	1.94e-06	0.000426	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EP300—uterine cancer	1.93e-06	0.000425	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL2—uterine cancer	1.93e-06	0.000424	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL8—uterine cancer	1.93e-06	0.000424	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.93e-06	0.000423	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NRAS—uterine cancer	1.92e-06	0.000421	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGFR2—uterine cancer	1.92e-06	0.00042	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.91e-06	0.00042	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—NRAS—uterine cancer	1.91e-06	0.000419	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL2—uterine cancer	1.89e-06	0.000416	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.88e-06	0.000412	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—uterine cancer	1.83e-06	0.000402	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PIK3CA—uterine cancer	1.82e-06	0.000399	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NRAS—uterine cancer	1.81e-06	0.000397	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PIK3CA—uterine cancer	1.81e-06	0.000397	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KRAS—uterine cancer	1.8e-06	0.000395	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KRAS—uterine cancer	1.79e-06	0.000392	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL2—uterine cancer	1.78e-06	0.00039	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PIK3CA—uterine cancer	1.77e-06	0.000389	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POLD1—uterine cancer	1.75e-06	0.000384	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—uterine cancer	1.75e-06	0.000384	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CA—uterine cancer	1.66e-06	0.000365	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CA—uterine cancer	1.65e-06	0.000363	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—uterine cancer	1.65e-06	0.000362	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—uterine cancer	1.64e-06	0.000361	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CA—uterine cancer	1.64e-06	0.00036	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ESR1—uterine cancer	1.64e-06	0.00036	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.64e-06	0.000359	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—STK11—uterine cancer	1.63e-06	0.000359	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.63e-06	0.000359	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—uterine cancer	1.62e-06	0.000356	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—uterine cancer	1.61e-06	0.000354	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CA—uterine cancer	1.61e-06	0.000353	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—STK11—uterine cancer	1.59e-06	0.00035	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP19A1—uterine cancer	1.59e-06	0.00035	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—uterine cancer	1.58e-06	0.000346	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—uterine cancer	1.56e-06	0.000342	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—NRAS—uterine cancer	1.55e-06	0.00034	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—uterine cancer	1.54e-06	0.000338	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.53e-06	0.000337	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—uterine cancer	1.53e-06	0.000336	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—uterine cancer	1.53e-06	0.000336	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—uterine cancer	1.52e-06	0.000333	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CA—uterine cancer	1.52e-06	0.000333	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CA—uterine cancer	1.51e-06	0.000331	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDKN1B—uterine cancer	1.5e-06	0.00033	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.5e-06	0.00033	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—STK11—uterine cancer	1.5e-06	0.00033	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—uterine cancer	1.5e-06	0.000329	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDKN1B—uterine cancer	1.49e-06	0.000328	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—STK11—uterine cancer	1.49e-06	0.000327	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.49e-06	0.000327	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—uterine cancer	1.49e-06	0.000326	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—uterine cancer	1.49e-06	0.000326	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—uterine cancer	1.48e-06	0.000325	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—uterine cancer	1.48e-06	0.000324	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—uterine cancer	1.47e-06	0.000322	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.46e-06	0.000321	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDKN1B—uterine cancer	1.46e-06	0.000321	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RRM2—uterine cancer	1.46e-06	0.00032	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—uterine cancer	1.45e-06	0.000317	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL2—uterine cancer	1.44e-06	0.000317	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CA—uterine cancer	1.43e-06	0.000314	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CTNNB1—uterine cancer	1.42e-06	0.000312	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DCN—uterine cancer	1.42e-06	0.000311	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CTNNB1—uterine cancer	1.41e-06	0.00031	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—uterine cancer	1.41e-06	0.000309	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—uterine cancer	1.4e-06	0.000308	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.4e-06	0.000307	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—uterine cancer	1.4e-06	0.000307	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—uterine cancer	1.38e-06	0.000304	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTEN—uterine cancer	1.38e-06	0.000304	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CTNNB1—uterine cancer	1.38e-06	0.000303	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—uterine cancer	1.38e-06	0.000302	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1B—uterine cancer	1.37e-06	0.000301	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—uterine cancer	1.36e-06	0.000298	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—uterine cancer	1.35e-06	0.000296	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—uterine cancer	1.35e-06	0.000296	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—uterine cancer	1.35e-06	0.000295	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—uterine cancer	1.34e-06	0.000294	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.34e-06	0.000293	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.33e-06	0.000293	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—uterine cancer	1.33e-06	0.000293	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—uterine cancer	1.32e-06	0.000291	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EP300—uterine cancer	1.32e-06	0.00029	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—uterine cancer	1.31e-06	0.000288	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EP300—uterine cancer	1.31e-06	0.000288	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—uterine cancer	1.3e-06	0.000285	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EP300—uterine cancer	1.28e-06	0.000282	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—uterine cancer	1.26e-06	0.000278	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.26e-06	0.000277	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—uterine cancer	1.25e-06	0.000274	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—uterine cancer	1.24e-06	0.000273	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—uterine cancer	1.24e-06	0.000272	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NRAS—uterine cancer	1.23e-06	0.000271	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—uterine cancer	1.23e-06	0.000271	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—uterine cancer	1.23e-06	0.000269	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NRAS—uterine cancer	1.23e-06	0.000269	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—uterine cancer	1.22e-06	0.000269	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—uterine cancer	1.22e-06	0.000267	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EP300—uterine cancer	1.21e-06	0.000265	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—uterine cancer	1.2e-06	0.000264	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NRAS—uterine cancer	1.2e-06	0.000264	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—uterine cancer	1.2e-06	0.000263	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—uterine cancer	1.18e-06	0.00026	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—uterine cancer	1.17e-06	0.000257	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—uterine cancer	1.14e-06	0.000251	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—uterine cancer	1.14e-06	0.00025	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—uterine cancer	1.13e-06	0.000249	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—EP300—uterine cancer	1.13e-06	0.000248	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—uterine cancer	1.13e-06	0.000248	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NRAS—uterine cancer	1.13e-06	0.000248	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—uterine cancer	1.12e-06	0.000246	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—uterine cancer	1.12e-06	0.000246	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	1.11e-06	0.000244	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	1.1e-06	0.000242	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.08e-06	0.000237	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—EP300—uterine cancer	1.07e-06	0.000234	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—uterine cancer	1.06e-06	0.000233	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—uterine cancer	1.06e-06	0.000232	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	1.05e-06	0.000231	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—uterine cancer	1.03e-06	0.000227	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—uterine cancer	1.03e-06	0.000225	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—uterine cancer	1e-06	0.00022	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.87e-07	0.000216	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—STK11—uterine cancer	9.82e-07	0.000216	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.82e-07	0.000216	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EP300—uterine cancer	9.78e-07	0.000215	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—uterine cancer	9.76e-07	0.000214	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—uterine cancer	9.71e-07	0.000213	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	9.7e-07	0.000213	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—uterine cancer	9.5e-07	0.000208	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—uterine cancer	9.45e-07	0.000207	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—uterine cancer	9.38e-07	0.000206	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—uterine cancer	9.26e-07	0.000203	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—uterine cancer	9.19e-07	0.000202	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NRAS—uterine cancer	9.15e-07	0.000201	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—uterine cancer	9.03e-07	0.000198	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—uterine cancer	8.97e-07	0.000197	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	8.92e-07	0.000196	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—uterine cancer	8.79e-07	0.000193	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—uterine cancer	8.63e-07	0.000189	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—uterine cancer	8.36e-07	0.000183	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—uterine cancer	8.25e-07	0.000181	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—uterine cancer	7.98e-07	0.000175	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—uterine cancer	7.92e-07	0.000174	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—uterine cancer	7.9e-07	0.000173	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—uterine cancer	7.88e-07	0.000173	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—uterine cancer	7.76e-07	0.00017	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—uterine cancer	7.38e-07	0.000162	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—uterine cancer	7.29e-07	0.00016	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	7.24e-07	0.000159	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—uterine cancer	7e-07	0.000154	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—uterine cancer	6.83e-07	0.00015	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—uterine cancer	6.83e-07	0.00015	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—uterine cancer	6.69e-07	0.000147	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—uterine cancer	6.67e-07	0.000146	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—EP300—uterine cancer	6.51e-07	0.000143	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—uterine cancer	6.46e-07	0.000142	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—EP300—uterine cancer	6.36e-07	0.00014	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—uterine cancer	6.28e-07	0.000138	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—uterine cancer	6.23e-07	0.000137	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—EP300—uterine cancer	5.99e-07	0.000131	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—EP300—uterine cancer	5.94e-07	0.00013	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—uterine cancer	5.91e-07	0.00013	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.82e-07	0.000106	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—uterine cancer	4.7e-07	0.000103	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.43e-07	9.73e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.39e-07	9.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—uterine cancer	4.11e-07	9.01e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—uterine cancer	3.94e-07	8.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—EP300—uterine cancer	3.92e-07	8.6e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—uterine cancer	3.84e-07	8.43e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—uterine cancer	3.62e-07	7.95e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—uterine cancer	3.59e-07	7.88e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.9e-07	6.36e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—uterine cancer	2.37e-07	5.19e-05	CbGpPWpGaD
